Skip to main content
Kevin Winthrop, MD, Infectious Disease, Portland, OR, Portland HCS

KevinLoringWinthropMD

Infectious Disease Portland, OR

Assistant Professor, Ophthalmology, Oregon Health and Science University School of Medicine

Are you Dr. Winthrop?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 42 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Kevin Winthrop, MD is an infectious disease specialist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Washington, and Florida. He is affiliated with Portland HCS and OHSU Hospital.

Education & Training

  • Legacy Health/Emanuel Medical Center
    Legacy Health/Emanuel Medical CenterResidency, Internal Medicine, 2004 - 2006
  • California Department of Public Health
    California Department of Public HealthFellowship, Maxillofacial Pathology, 2002 - 2002
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - Present
  • OR State Medical License
    OR State Medical License 2004 - 2025
  • WA State Medical License
    WA State Medical License 2024 - 2024
  • FL State Medical License
    FL State Medical License 2018 - 2020
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • JAK Inhibitors Show No Excess Cardiovascular Safety Signal in French Nationwide Cohort
    JAK Inhibitors Show No Excess Cardiovascular Safety Signal in French Nationwide CohortOctober 20th, 2022
  • JAK Inhibitors Show No Excess Cardiovascular Safety Signal in French Nationwide Cohort
    JAK Inhibitors Show No Excess Cardiovascular Safety Signal in French Nationwide CohortOctober 19th, 2022
  • Monoclonal Antibody, Antiviral Therapies Struggle to Keep Pace with COVID-19 Variants
    Monoclonal Antibody, Antiviral Therapies Struggle to Keep Pace with COVID-19 VariantsFebruary 11th, 2022
  • Join now to see all

Grant Support

  • Mycobacterial Disease Prevention: Pharmacovigilance And Inflammatory DiseaseAgency For Healthcare Research And Quality2008–2010

Hospital Affiliations